Zyprexa 5 (Olanzapine Vials) 5mg/ml

ZYPREXA 5 (Olanzapine 5mg/ml) is an antipsychotic medication available in vial form. It is commonly used for managing symptoms of schizophrenia and bipolar disorder. Store at ambient temperature and keep out of reach of children. Always follow healthcare provider instructions when using this medication.

Strength

5mg/ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Eli Lilly

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZYPREXA 5 (Olanzapine 5mg/ml) is primarily used to treat symptoms associated with schizophrenia and bipolar disorder. It helps manage conditions like hallucinations, delusions, and mood swings. This medication is also used in combination with other treatments for certain mental health conditions. It is not intended for use without a prescription.

Side Effects

ZYPREXA 5 (Olanzapine 5mg/ml) may help reduce symptoms of mental health conditions by affecting certain chemicals in the brain. Users may experience improved mood stability and reduced agitation. Some individuals report feeling calmer or more focused after starting this medication. Effects vary by person and condition.

Precautions & Warnings

Keep ZYPREXA 5 (Olanzapine 5mg/ml) in its original packaging at room temperature. Protect from light and moisture. Do not use if the solution is discolored or contains particles. Always check the expiration date before use. Discard unused medication properly according to local guidelines.

Avoid Interactions

ZYPREXA 5 (Olanzapine 5mg/ml) may interact with alcohol, other central nervous system depressants, or medications that affect liver enzymes. Avoid combining it with substances that cause drowsiness unless directed by a healthcare provider. Inform your doctor about all medications, supplements, or herbal products you are using.

Frequently Asked Questions

ZYPREXA 5 (Olanzapine 5mg/ml) is used to treat symptoms of schizophrenia and bipolar disorder.

Store ZYPREXA 5 at room temperature, away from light and moisture. Do not freeze.

Alcohol may increase certain side effects of ZYPREXA 5. Consult a healthcare provider before combining them.

No, ZYPREXA 5 requires a prescription from a licensed healthcare provider.

If a dose is missed, contact your healthcare provider for guidance. Do not take a double dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.